Avidity Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	1,924	671	1,209	1,115	958	-	-
Market Cap Growth	-	-44.51%	8.41%	16.40%	-	-	-
Enterprise Value	1,338	85	608	721	630	-90	7
PE Ratio	-3.16	-3.16	-6.95	-9.45	-21.59	-	-
PS Ratio	201.22	70.15	131.02	119.53	141.10	-	-
PB Ratio	3.84	1.34	2.09	2.92	3.13	-	-
P/FCF Ratio	-5.44	-5.44	-8.69	-11.31	-25.06	-	-
P/OCF Ratio	-5.63	-5.63	-8.87	-11.76	-25.80	-	-
EV/Sales Ratio	139.94	8.87	65.94	77.28	92.86	-38.66	19.09
EV/EBITDA Ratio	-0.41	-0.41	-3.58	-6.18	-14.40	5.27	-0.72
EV/EBIT Ratio	-0.40	-0.40	-3.50	-6.11	-14.28	5.17	-0.69
EV/FCF Ratio	-0.69	-0.69	-4.37	-7.31	-16.49	-39.75	-0.75
Debt / Equity Ratio	0.02	0.02	0.02	0.03	0.00	-0.08	-0.25
Debt / EBITDA Ratio	-0.05	-0.05	-0.06	-0.10	-0.02	-0.29	-1.02
Debt / FCF Ratio	-0.08	-0.08	-0.08	-0.12	-0.02	2.19	-1.06
Quick Ratio	7.38	7.38	11.77	13.68	22.51	9.24	0.67
Current Ratio	7.58	7.58	12.00	13.86	22.74	9.35	0.70
Asset Turnover	0.02	0.02	0.02	0.03	0.02	0.05	-
Interest Coverage	-	-	-	-	-211.22	-2.35	-14.62
Return on Equity (ROE)	-39.70%	-39.70%	-40.80%	-35.60%	-20.00%	46.50%	-
Return on Assets (ROA)	-35.00%	-35.00%	-36.40%	-32.40%	-15.70%	-49.00%	-
Return on Capital (ROIC)	-46.14%	-46.14%	-30.39%	-30.03%	-14.41%	28.69%	34.08%
Earnings Yield	-11.03%	-31.65%	-14.40%	-10.59%	-4.63%	-	-
FCF Yield	-6.41%	-18.38%	-11.51%	-8.84%	-3.99%	-	-
Buyback Yield / Dilution	-39.97%	-39.97%	-25.91%	-91.24%	-698.49%	-9.53%	-
Total Shareholder Return	-39.97%	-39.97%	-25.91%	-91.24%	-698.49%	-9.53%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).